Sort
10,766 grants matching “checkpoint inhibitor”
ADENOSINE BLOCKADE WITH RADIOTHERAPY TO ENHANCE RESPONSES OF BREAST CANCER TO IMMUNE CHECKPOINT INHIBITORS
$507,939Weill Medical College Of Cornell University · · FY2017 · Department of the Army
Cancer Center Research Training Program
$507,871Michael D Hogarty · University Of Pennsylvania · T32 · FY2025 · CA
Intravesical Immunotherapy of Spontaneous Canine Invasive Urothelial Carcinoma
$507,574David Zaharoff · North Carolina State University Raleigh · U01 · FY2024 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$507,564Roger S Lo · University Of California Los Angeles · P01 · FY2022 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$507,564Thomas G Graeber · University Of California Los Angeles · P01 · FY2023 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$507,564Thomas G Graeber · University Of California Los Angeles · P01 · FY2022 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$507,563Roger S Lo · University Of California Los Angeles · P01 · FY2023 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$507,430Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Nanovaccine platforms to combat pancreatic cancer
$507,337Balaji Narasimhan · Iowa State University · U01 · FY2021 · CA
Function of Wdfy4 in cross-presentation and immunity
$507,323Kenneth M. Murphy · Washington University · R01 · FY2022 · AI
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$507,066Justin M Balko · Vanderbilt University Medical Center · R01 · FY2022 · CA
GENOTOXIC RESPONSES
$506,874Trey Ideker · University Of California, San Diego · P50 · FY2012 · GM
Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex
$506,772Elizabeth P Henske · Brigham And Women'S Hospital · R01 · FY2024 · DK
Radioprotective effect of p53 against oral mucositis
$506,768Chang-Lung Lee · Duke University · R01 · FY2023 · DE
Identifying and targeting neoantigens in aggressive salivary carcinomas
$506,762Luc Gordon Trang Morris · Sloan-Kettering Inst Can Research · R01 · FY2021 · DE
Acute Kidney Injury and Double Negative T Cells
$506,667Abdel Hamad · Johns Hopkins University · R01 · FY2021 · DK
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$506,606Jung Soo Suk · Johns Hopkins University · R01 · FY2021 · NS
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$506,599Anant Madabhushi · Emory University · R01 · FY2024 · CA
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$506,551Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Genetic screens for IR resistance
$506,521Stephen J Elledge · Dana-Farber Cancer Inst · U19 · FY2007 · AI
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
$506,448Barbara Burtness · Yale University · P50 · FY2022 · DE
Spatially precise radio-chemo-immunotherapy using antibody conjugates
$506,426Sunil J Advani · University Of California, San Diego · R01 · FY2024 · CA
Nanovaccine platforms to combat pancreatic cancer
$506,063Balaji Narasimhan · Iowa State University · U01 · FY2020 · CA
Repurposing drugs and finding new therapeutic targets for cutaneous malignancies
$505,981Natasha Hill · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2023 · AR
Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms
$505,973Jung Soo Suk · Johns Hopkins University · R01 · FY2022 · NS